Stay updated on MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Sign up to get notified when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.2 to v3.6.3, indicating a newer version of the page.
    Difference
    0.1%
    Check dated 2026-07-03T23:40:15.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The page revision changed from v3.6.0 to v3.6.2, signaling a backend version update. No user-facing content or behavior was modified.
    Difference
    0.1%
    Check dated 2026-06-26T20:23:31.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Recruitment status updated to not currently enrolling participants. New navigation sections—How to Read a Study Record, Common Questions, and How to Join a Study—were added, and the Intervention/Treatment heading formatting was updated along with the revision label from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T11:43:52.000Z thumbnail image
  5. Check
    41 days ago
    Change Detected
    Summary
    The page’s revision number was updated from v3.5.4 to v3.5.5, signaling a backend release with no impact on the study data or user-facing information.
    Difference
    0.1%
    Check dated 2026-06-05T08:29:53.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page revision label changes from v3.5.3 to v3.5.4, indicating a new version of the page rather than substantive changes to the study details.
    Difference
    0.1%
    Check dated 2026-05-14T23:08:08.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    The page’s revision/version label has been updated from v3.5.2 to v3.5.3, reflecting a deployed update to the page. No changes to the study details or other substantive content are indicated.
    Difference
    0.1%
    Check dated 2026-04-30T15:55:22.000Z thumbnail image

Stay in the know with updates to MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the MAPK Therapy + Pembrolizumab in Melanoma Clinical Trial page.